The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.83BCNY
1.47B · vs all stocks (USD)
Updated Nov 18, 2026
Revenue (TTM)
4.16BCNY
623.97M · vs all stocks (USD)
Updated Nov 18, 2026
Profit Margin
-2.16%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Beta
0.1290x
vs all stocks
Updated Nov 18, 2026
52-Week Change
-8.35%
vs all stocks
Updated Nov 18, 2026
Market Capitalization
9.83BCNY
1.47B · vs all stocks (USD)
Updated Nov 18, 2026
Enterprise Value
13.43BCNY
2.01B · vs all stocks (USD)
Updated Nov 18, 2026
Forward P/E
34.23x
vs Medical Care Facilities peers
Updated Nov 18, 2026
Price to Sales (TTM)
2.39x
vs Medical Care Facilities peers
Updated Nov 18, 2026
Price to Book (MRQ)
3.07x
vs Medical Care Facilities peers
Updated Nov 18, 2026
Enterprise to Revenue
3.23x
vs Medical Care Facilities peers
Updated Nov 18, 2026
Enterprise to EBITDA
24.09x
vs Medical Care Facilities peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 32.3×.Updated Nov 18, 2026
Gross Margin
14.98%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 12.9%.Updated Nov 18, 2026
Profit Margin
-2.16%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Operating Margin
-1.70%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Return on Assets (TTM)
-0.46%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Return on Equity (TTM)
-6.55%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Revenue (TTM)
4.16BCNY
623.97M · vs all stocks (USD)
Updated Nov 18, 2026
Revenue per Share (TTM)
1.87CNYUpdated Nov 18, 2026
Quarterly Revenue Growth
9.10%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Gross Profit (TTM)
536.47MCNY
80.46M · vs all stocks (USD)
Updated Nov 18, 2026
EBITDA (TTM)
415.81MCNY
62.37M · vs all stocks (USD)
Updated Nov 18, 2026
Net Income (TTM)
-89.80MCNY
-13.47M · vs all stocks (USD)
Updated Nov 18, 2026
Quarterly Earnings Growth (YoY)
6.58%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Operating Cash Flow (TTM)
1.30BCNY
195.47M · vs all stocks (USD)
Updated Nov 18, 2026
Levered Free Cash Flow (TTM)
403.25MCNY
60.48M · vs all stocks (USD)
Updated Nov 18, 2026
5-Year Average Dividend Yield
0.46%
vs all stocks
Updated Nov 18, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Nov 18, 2026
Minority Interest (Equity)
-310.89MCNYFY2025 · Dec 31, 2025
Revenue
4.07BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.74BCNYFY2025 · Dec 31, 2025
Gross Profit
336.41MCNYFY2025 · Dec 31, 2025
Operating Income
-300.14MCNY
-45.02M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-400.30MCNYFY2025 · Dec 31, 2025
Income Tax Expense
20.73MCNYFY2025 · Dec 31, 2025
Net Income
-421.03MCNYFY2025 · Dec 31, 2025
EBIT
-262.41MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
415.81MCNYFY2025 · Dec 31, 2025
Research & Development
7.63MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
210.46MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
82.91MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.84MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
137.89MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1400CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1400CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.24BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.24BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-421.03MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
107.95MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-63.09MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-291.36MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
389.14MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-421.03MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
153.93MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
177.74MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
26.27MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-228.28MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
102.16MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-127.11MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
493.01MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.59BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-149.21MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-59.38MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.31BCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.24BSharesUpdated Nov 18, 2026
Float Shares
1.55BSharesUpdated Nov 18, 2026
% Held by Insiders
34.05%
vs all stocks
Updated Nov 18, 2026
% Held by Institutions
1.01%
vs all stocks
Updated Nov 18, 2026
Total Cash (MRQ)
379.74MCNY
56.96M · vs all stocks (USD)
Updated Nov 18, 2026
Total Cash per Share (MRQ)
0.1700CNYUpdated Nov 18, 2026
Total Debt (MRQ)
4.12BCNY
618.44M · vs all stocks (USD)
Updated Nov 18, 2026
Total Debt to Equity (MRQ)
1.44x
vs Medical Care Facilities peers
Updated Nov 18, 2026
Current Ratio (MRQ)
0.2460x
vs Medical Care Facilities peers
Updated Nov 18, 2026
Book Value per Share (MRQ)
1.45CNYUpdated Nov 18, 2026
Total Assets
9.71BCNY
1.46B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.13BCNYFY2025 · Dec 31, 2025
Total Liabilities
6.70BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
8.58BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.25BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
4.45BCNYFY2025 · Dec 31, 2025
Cash
388.96MCNYFY2025 · Dec 31, 2025
Cash Equivalents
22.47MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
411.44MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
12.92MCNYFY2025 · Dec 31, 2025
Accounts Receivable
518.62MCNYFY2025 · Dec 31, 2025
Inventory
67.23MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.73BCNYFY2025 · Dec 31, 2025
Short-term Debt
2.06BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
415.09KCNYFY2025 · Dec 31, 2025
Long-term Debt
2.17BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.41MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.24BCNYFY2025 · Dec 31, 2025
Retained Earnings
-293.10MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.01BCNY
451.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.82CNYUpdated Nov 18, 2026
52-Week High
6.19CNYUpdated Nov 18, 2026
52-Week Change
-8.35%
vs all stocks
Updated Nov 18, 2026
Beta
0.1290x
vs all stocks
Updated Nov 18, 2026
50-Day MA
4.39CNYUpdated Nov 18, 2026
200-Day MA
4.45CNYUpdated Nov 18, 2026
Avg 10-Day Volume
29.00MSharesUpdated Nov 18, 2026
Avg 30-Day Volume
24.58MSharesUpdated Nov 18, 2026
Diluted EPS (TTM)
-0.0400CNYUpdated Nov 18, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -1.7%, lower than 95% of its Medical Care Facilities peers (median 11.5%)Significant